Morgan Stanley Cv Rx, Inc. Transaction History

Morgan Stanley

$1.49 Trillion
Q2 2025

A detailed history of Morgan Stanley transactions in Cv Rx, Inc. stock. As of the latest transaction made, Morgan Stanley holds 368,251 shares of CVRX stock, worth $2.77 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

368,251

Previous 199,005 85.05%

Holding current value

$2.77 Million

Previous $2.43 Million 11.02%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 15, 2025	BUY	$4.75 - $12.98 $803,918 - $2.2 Million	169,246 Added 85.05%	368,251 $2.17 Million
Q1 2025 May 15, 2025	SELL	$11.05 - $18.4 $178,236 - $296,792	-16,130 Reduced 7.5%	199,005 $2.43 Million
Q4 2024 Feb 14, 2025	SELL	$6.95 - $15.83 $112,235 - $255,638	-16,149 Reduced 6.98%	215,135 $2.73 Million
Q3 2024 May 14, 2025	BUY	$7.15 - $12.37 $285,113 - $493,266	39,876 Added 20.83%	231,284 $2.04 Million
Q3 2024 Nov 14, 2024	BUY	$7.15 - $12.37 $285,113 - $493,266	39,876 Added 20.83%	231,284 $2.04 Million
Q2 2024 May 14, 2025	SELL	$6.49 - $19.2 $153,988 - $455,558	-23,727 Reduced 11.03%	191,408 $2.29 Million
Q2 2024 Oct 17, 2024	SELL	$6.49 - $19.2 $74,037 - $219,033	-11,408 Reduced 5.62%	191,408 $2.29 Million
Q2 2024 Aug 14, 2024	SELL	$6.49 - $19.2 $74,037 - $219,033	-11,408 Reduced 5.62%	191,408 $2.29 Million
Q1 2024 Oct 17, 2024	BUY	$17.99 - $30.49 $205,229 - $347,829	11,408 Added 5.96%	202,816 $3.69 Million
Q1 2024 Aug 16, 2024	BUY	$17.99 - $30.49 $1.68 Million - $2.84 Million	93,176 Added 84.98%	202,816 $3.69 Million
Q1 2024 May 15, 2024	BUY	$17.99 - $30.49 $1.68 Million - $2.84 Million	93,176 Added 84.98%	202,816 $3.69 Million
Q4 2023 Aug 16, 2024	SELL	$11.67 - $33.01 $954,232 - $2.7 Million	-81,768 Reduced 42.72%	109,640 $3.45 Million
Q4 2023 Feb 13, 2024	BUY	$11.67 - $33.01 $594,539 - $1.68 Million	50,946 Added 86.8%	109,640 $3.45 Million
Q3 2023 Nov 15, 2023	SELL	$13.56 - $18.47 $52,531 - $71,552	-3,874 Reduced 6.19%	58,694 $890,000
Q2 2023 Aug 14, 2023	SELL	$8.57 - $15.44 $73,350 - $132,150	-8,559 Reduced 12.03%	62,568 $966,000
Q1 2023 May 15, 2023	BUY	$7.08 - $19.4 $397,747 - $1.09 Million	56,179 Added 375.83%	71,127 $662,000
Q4 2022 Feb 14, 2023	BUY	$8.94 - $18.35 $51,995 - $106,723	5,816 Added 63.69%	14,948 $274,000
Q3 2022 Nov 14, 2022	SELL	$6.12 - $9.5 $86,830 - $134,786	-14,188 Reduced 60.84%	9,132 $85,000
Q2 2022 Oct 27, 2022	SELL	$4.7 - $7.22 $66,669 - $102,415	-14,185 Reduced 37.82%	23,320 $141,000
Q2 2022 Aug 15, 2022	SELL	$4.7 - $7.22 $66,669 - $102,415	-14,185 Reduced 37.82%	23,320 $141,000
Q1 2022 Oct 27, 2022	BUY	$5.62 - $12.37 $79,719 - $175,468	14,185 Added 60.83%	37,505 $224,000
Q1 2022 May 13, 2022	BUY	$5.62 - $12.37 $155,190 - $341,585	27,614 Added 279.18%	37,505 $224,000
Q4 2021 Feb 14, 2022	SELL	$10.65 - $18.61 $3,024 - $5,285	-284 Reduced 2.79%	9,891 $122,000
Q3 2021 Nov 15, 2021	BUY	$14.65 - $26.07 $149,063 - $265,262	10,175 New	10,175 $169,000

Others Institutions Holding CVRX

# of Institutions

Shares Held

14.9M

Call Options Held

42.2K

Put Options Held

32.4K

View Full List

About CVRx, Inc.

Ticker CVRX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 20,576,200
Market Cap $155M
Description
CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The co...

More about CVRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account